July 23, 2018 / 4:29 AM / a month ago

REFILE-BRIEF-Changsheng Bio-Technology And Changchun Changsheng Are Cooperating With Drug Regulator On Self-Inspection

(Refiles to add bullet points, links)

July 23 (Reuters) - Changsheng Bio-technology Co Ltd :

* SAYS IT AND CHANGCHUN CHANGSHENG ARE ACTIVELY AND STRICTLY COOPERATING WITH DRUG REGULATOR ON SELF-INSPECTION

* SAYS IT IS UNCERTAIN WHEN IT CAN RESUME PRODUCTION

* SAYS THE HALT OF PRODUCTION WILL HAVE SIGNIFICANT IMPACT ON COMPANY’S PRODUCTION AND OPERATION AND HARM CO’S INTEGRITY AND SOCIAL RESPONSIBILITY IMAGE

* SAYS WARNS INVESTORS ON INVESTMENT RISKS

* SAYS SHARE TRADE TO RESUME FROM AFTERNOON TRADING ON JULY 23

* SAYS IT IS INVESTIGATED BY SECURITIES REGULATOR DUE TO SUSPECTED VIOLATION OF INFORMATION DISCLOSURE

* SAYS CONTROLLING SHAREHOLDER HAS PLEDGED 73.36 MLN SHARES IN THE COMPANY AS COLLATERAL ON JULY 20

* SAYS CONTROLLING SHAREHOLDER AND PARTIES ACTING IN CONCERT HAVE PLEDGED 166.9 MLN SHARES, OR 17.14 PCT STAKE IN THE COMPANY AS COLLATERAL

* SAYS IT FACES DELISTING RISK WARNING DEPENDING ON OUTCOME OF INVESTIGATION Source text in Chinese: bit.ly/2LDv7Ol; bit.ly/2Lj3VZv; bit.ly/2mztKFz Further company coverage: (Reporting by Hong Kong newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below